2025-03-12 13:02:21
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Anuh Pharma Ltd Q4 FY2023 PAT up at Rs. 9.62 crores
Posted On : 2023-05-19 21:25:10( TIMEZONE : IST )
ANUH PHARMA LTD. has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 158.3470 crores during the period ended March 31, 2023 as compared to Rs. 140.8425 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 9.6230 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 9.3061 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 1.92 for the period ended March 31, 2023 as compared to Rs. 1.86 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹158.3470 crs | ₹140.8425 crs |  12.43% |
| Net Profit | ₹9.6230 crs | ₹9.3061 crs | 3.41% |
| EPS | ₹1.92 | ₹1.86 | 3.23% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.158.3470 crores during the period ended March 31, 2023 as compared to Rs.129.9987 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.9.6230 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.8.9255 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.1.92 for the period ended March 31, 2023 as compared to Rs.1.78 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹158.3470 crs | ₹129.9987 crs | 21.81% |
| Net Profit | ₹9.6230 crs | ₹8.9255 crs | 7.81% |
| EPS | ₹1.92 | ₹1.78 | 7.87% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.533.6005 crores during the Financial Year ended March 31, 2023 as compared to Rs.491.8433 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.36.1796 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.30.5613 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.7.22 for the Financial Year ended March 31, 2023 as compared to Rs.6.10 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹533.6005 crs | ₹491.8433 crs | 8.49% |
| Net Profit | ₹36.1796 crs | ₹30.5613 crs | 18.38% |
| EPS | ₹7.22 | ₹6.10 | 18.36% |
Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 95.83 as compared to the previous close of Rs. 93.94. The total number of shares traded during the day was 77125 in over 779 trades.
The stock hit an intraday high of Rs. 96.80 and intraday low of 92.00. The net turnover during the day was Rs. 7330077.00.
